Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Stockholders Equity of $1.34 million for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.34M | -88.2% |
| 2024 | $11.31M | +367.5% |
| 2023 | -$4.23M | -112.1% |
| 2023 | $35.02M | -50.8% |
| 2022 | $71.14M | -8.6% |
| 2022 | $77.88M | -11.3% |
| 2022 | $87.82M | -38.4% |
| 2022 | $142.56M | -8.3% |
| 2021 | $155.42M | -19.5% |
| 2021 | $193.12M | -4.4% |
| 2021 | $201.95M | -0.1% |
| 2021 | $202.20M | -2.8% |
| 2020 | $208.00M | -4.8% |
| 2020 | $218.54M | -4.9% |
| 2020 | $229.84M | -14.9% |
| 2019 | $270.14M | +7.0% |
| 2018 | $252.56M | +11.5% |
| 2017 | $226.61M | +7.5% |
| 2016 | $210.73M | -3.5% |
| 2015 | $218.43M | +7.6% |
| 2014 | $203.07M | +13.6% |
| 2013 | $178.69M | +19.3% |
| 2012 | $149.74M | +10.1% |
| 2011 | $136.06M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.54M | — | -1123.8% |
| June 30, 2025 | -$861.0K | — | -164.4% |
| May 31, 2025 | $1.34M | -88.2% | -40.1% |
| February 28, 2025 | $2.23M | -87.4% | -85.6% |
| November 30, 2024 | $15.45M | +987.2% | +492.2% |
| August 31, 2024 | -$3.94M | +71.0% | -134.8% |
| May 31, 2024 | $11.31M | +367.5% | -36.0% |
| February 29, 2024 | $17.69M | -49.5% | +1144.6% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -88.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s stockholders equity has declined by 99.0% (from $136.06 million to $1.34 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: